County board commissioners from at least six Minnesota counties have authorized attorneys to enter agreements with private law firms to either file a lawsuit or consider litigation against drugmakers and distributors to recoup expenses related to the public cost of…
Public Health
America's opioid crisis cost the U.S. economy more than $500 billion in 2015, dwarfing previous annual estimates produced by multiple groups of researchers, according to a report conducted by the White House's Council of Economic Advisers.
The total number of drug overdose deaths in Florida increased by 22 percent from 2015 to 2016, with opioid-related overdoses increasing 35 percent, according to a report compiled by the state's medical examiners released Wednesday and cited by The News…
Cardinal Health launched its Opioid Action Program Thursday to help communities in the four states hit hardest by the opioid epidemic — Ohio, Kentucky, Tennessee and West Virginia.
The fiscal burden related to opioid-related overdoses and deaths in 2016 exceeded $95 billion, according to an analysis conducted by Altarum.
Nuisance ordinances in Ohio's Cuyahoga County often result in fines for residents who call 911 for incidences of domestic violence and drug overdoses, according to a study from Cleveland State University featured by Cleveland.com.
The Food and Drug Administration granted market clearance for Innovative Health Solutions' nerve stimulation device Wednesday.
The City of Indianapolis on Tuesday filed a federal lawsuit against multiple drugmakers and drug distributors for their alleged role in facilitating widespread opioid use in the city and Marion County, according to a report from IndyStar.
In light of HHS declaring the U.S. opioid overdose crisis a public health emergency Oct. 26, the American Health Information Management Association released a set of seven characteristics providers should aim for when documenting opioid addiction in patient charts.
Ymir Genomics and the Knight Cancer Institute at Portland-based Oregon Health & Science University are joining forces to develop urinary biomarkers that will be able to detect hepatocellular carcinoma in at-risk patients.